Back to search results

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE4

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Yale School of Medicine, New Haven, Connecticut, United States

    Contact: Study coordinator (Katerina Palma) · Katerina.palma@yale.edu
    Contact: Principal Investigator (Erin Longbrake)

  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (David Pisfil) · ddp39@georgetown.edu · 202-444-4289
    Contact: Principal Investigator (Benjamin Osborne, MD)

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Caroline Gebczak) · caroline.gebczak@northwestern.edu · 630-313-0470
    Contact: Study coordinator (Dylan Rice) · dylan.rice@northwestern.edu · 240-362-4800
    Contact: Principal Investigator (Farrah Mateen, MD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Aisha Seard) · aseard@mgh.harvard.edu · 617-726-7565
    Contact: Principal Investigator (Michael Levy, MD)

  • University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

    Contact: Study coordinator (Irina Radu) · irina.radu@umassmed.edu · 774-520-4435
    Contact: Study coordinator (Mariana Kurban) · mariana.kurban@umassmed.edu · (774) 519-2005
    Contact: Principal Investigator (Carolina Ionete)

  • RWJ Barnabas Health, Livingston, New Jersey, United States

    Contact: Study coordinator (Joshua-Daniel Bishop-Mbachu) · Joshua-Daniel.Bishop-Mbachu@rwjbh.org · 973-322-7509
    Contact: Principal Investigator (Matthew Tremblay, MD)

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Nicole Graziano) · nicole.graziano@mssm.edu · 212-241-3391
    Contact: Principal Investigator (Aaron Miller)

  • University of Rochester Medical Center, Rochester, New York, United States

    Contact: Study coordinator (Jennifer Voelkl) · jenniferm_voelkl@urmc.rochester.edu · 585-276-3513
    Contact: Principal Investigator (Andrew Goodman)

  • Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Kellie Kraus) · kellie-kraus@omrf.org · 405-271-7135
    Contact: Principal Investigator (Gabriel Pardo)

  • University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Kristen Fleming) · Kristen.fleming@pennmedicine.upenn.edu
    Contact: Principal Investigator (Amit Bar-Or)

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Manuel Huichapa) · manuel.huichapa@utsouthwestern.edu · 214-645-8216
    Contact: Principal Investigator (Ben Greenberg)

  • The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States

    Contact: Study coordinator (Tanya Khan) · Tanya.S.Khan@uth.tmc.edu · 713-704-0823
    Contact: Principal Investigator (John Lindsey, MD)

  • Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States

    Contact: Study coordinator (Aarati Pokharel) · Aarati.Pokharel@vcuhealth.org · 540-394-1373
    Contact: Principal Investigator (Ryan Canissario, MD)
    Contact: Principal Investigator (Myla Goldman, MD)
Study leads

  • Amit Bar-Or, M.D.

    Study Chair

    University of Pennsylvania, Perelman School of Medicine: Department of Neurology

View source on ClinicalTrials.gov(opens in a new tab)